Literature DB >> 7944625

Methotrexate-related pulmonary complications in patients with rheumatoid arthritis: cluster of five cases in a period of three months.

P Barrera, A Van Ede, R F Laan, P L Van Riel, A M Boerbooms, L B Van De Putte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7944625      PMCID： PMC1005377          DOI： 10.1136/ard.53.7.479

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

1.  Methotrexate, pneumonitis, and infection.

Authors:  P J Kerstens; J W Van Loenhout; A M Boerbooms; L B Van De Putte
Journal:  Ann Rheum Dis       Date:  1992-10       Impact factor: 19.103

2.  Low dose methotrexate treatment in systemic sclerosis.

Authors:  F H van den Hoogen; A M Boerbooms; L B van de Putte; J J Rasker; W J van Venrooij
Journal:  J Rheumatol       Date:  1991-11       Impact factor: 4.666

3.  The clinical and health status of patients with recent-onset rheumatoid arthritis.

Authors:  R F Meenan; L E Kazis; J M Anthony; B A Wallin
Journal:  Arthritis Rheum       Date:  1991-06

Review 4.  Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors. Four case reports and a review of the literature.

Authors:  G Searles; R J McKendry
Journal:  J Rheumatol       Date:  1987-12       Impact factor: 4.666

5.  Bronchoalveolar lavage in rheumatoid arthritis.

Authors:  G Kolarz; O Scherak; W Popp; L Ritschka; N Thumb; A Wottawa; H Zwick
Journal:  Br J Rheumatol       Date:  1993-07

6.  Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate.

Authors:  C W Carson; G W Cannon; M J Egger; J R Ward; D O Clegg
Journal:  Semin Arthritis Rheum       Date:  1987-02       Impact factor: 5.532
  6 in total
  2 in total

Review 1.  Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: report of five cases and review of the literature.

Authors:  F Salaffi; P Manganelli; M Carotti; S Subiaco; G Lamanna; C Cervini
Journal:  Clin Rheumatol       Date:  1997-05       Impact factor: 2.980

2.  Nintedanib reduces pulmonary fibrosis in a model of rheumatoid arthritis-associated interstitial lung disease.

Authors:  Elizabeth F Redente; Martin A Aguilar; Bart P Black; Benjamin L Edelman; Ali N Bahadur; Stephen M Humphries; David A Lynch; Lutz Wollin; David W H Riches
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-03-15       Impact factor: 5.464
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.